TNGX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Tango Therapeutics Inc

Watchlist Manager

Watchlist

Price: 26.63 USD -2.99% Market Closed

Market Cap: $4.3B

	Tango Therapeutics Inc NASDAQ:TNGX	US
	Citizens Inc F:YCX	US
	Beijing Enterprises Water Group Ltd HKEX:371	HK
I	IDT Corp F:IDC2	US
	M&G PLC LSE:MNG	UK
	Sekisui House Ltd F:SPH1	JP

Profitability Summary

Tango Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-178%

Negative 3Y Average Operating Margin

-328%

Operating Margin is Increasing

-338% > -178%

Negative Net Margin

-163%

Negative 3Y Average Net Margin

-297%

Net Margin is Increasing

-317% > -163%

Negative Free Cash Flow Margin

-224%

Negative 3Y Average Free Cash Flow Margin

-326%

Free Cash Flow Margin is Increasing

-335% > -224%

Negative ROE

-37%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-221%

ROIC is Increasing

-243% > -200%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.